These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 31190990)

  • 21. Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A pilot study.
    Mahmoud AM; Ismail YM; Hussien A; Debaky Y; Ahmed IS; Mikhael HSW; Moneer M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):143-150. PubMed ID: 30472198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre.
    Tan G; Chia C; Kumar M; Choo SP; Chia J; Tham CK; Chua C; Soo KC; Teo M
    Int J Hyperthermia; 2017 May; 33(3):288-294. PubMed ID: 27855557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis.
    Lee ZJ; Chia SL; Tan G; Soo KC; Teo CCM
    Ann Surg Oncol; 2018 Aug; 25(8):2340-2346. PubMed ID: 29948417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally Invasive Surgical Approaches for Peritoneal Surface Malignancy.
    Enomoto LM; Levine EA; Perry KC; Votanopoulos KI; Kuncewitch M; Shen P
    Surg Oncol Clin N Am; 2019 Apr; 28(2):161-176. PubMed ID: 30851821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma.
    Tan GH; Cheung M; Chanyaputhipong J; Soo KC; Teo MC
    Ann Acad Med Singap; 2013 Jun; 42(6):291-6. PubMed ID: 23842770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases.
    Königsrainer I; Horvath P; Struller F; Königsrainer A; Beckert S
    J Gastric Cancer; 2014 Jun; 14(2):117-22. PubMed ID: 25061539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
    Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of intravenous versus bidirectional chemotherapy after cytoreductive surgery for malignant peritoneal mesothelioma.
    Sugarbaker PH
    Int J Surg Protoc; 2023 Dec; 27(3):108-117. PubMed ID: 38046900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Communicating imaging findings in peritoneal mesothelioma: the impact of 'PAUSE' on surgical decision-making.
    Chandramohan A; Shah N; Thrower A; Carr NJ; Mittal R; Mohamed F; Moran B
    Insights Imaging; 2021 Nov; 12(1):174. PubMed ID: 34817720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC; Yan TD; Morris DL
    J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases.
    Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A
    Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of management and treatment of peritoneal metastases from gastric cancer origin.
    Manzanedo I; Pereira F; Serrano Á; Pérez-Viejo E
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S20-S29. PubMed ID: 33968423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis.
    Roh SJ; Park SC; Choi J; Lee JS; Lee DW; Hong CW; Han KS; Park HC; Sohn DK; Oh JH
    Ann Coloproctol; 2020 Feb; 36(1):22-29. PubMed ID: 32146785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.
    Wong JF; Tan GH; Wang W; Soo KC; Teo MC
    World J Surg; 2015 Jun; 39(6):1578-83. PubMed ID: 25651962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical Management of Peritoneal Surface Malignancy with Respect to Tumour Type, Tumour Stage and Individual Tumour Biology].
    Beckert S; Struller F; Grischke EM; Glatzle J; Zieker D; Königsrainer A; Königsrainer I
    Zentralbl Chir; 2016 Aug; 141(4):415-20. PubMed ID: 24241953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
    Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH
    J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly Patients: Complete Cytoreduction Is Feasible and Crucial for Improved Survival Despite High Carcinomatosis Index.
    Naffouje SA; Salti GI
    Anticancer Res; 2018 Jan; 38(1):441-448. PubMed ID: 29277807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study.
    Paasch C; De Santo G; Gamal-Eldin HN; Hünerbein M
    Ann Med Surg (Lond); 2021 Oct; 70():102824. PubMed ID: 34584682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.